SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-21-000060
Filing Date
2021-12-01
Accepted
2021-12-01 08:27:14
Documents
14
Period of Report
2021-11-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim-20211130x8k.htm   iXBRL 8-K 82808
2 EX-99.1 alim-20211130xex99_1.htm EX-99.1 25991
3 GRAPHIC alim-20211130xex99_1g001.jpg GRAPHIC 23407
  Complete submission text file 0001267602-21-000060.txt   266033

Data Files

Seq Description Document Type Size
4 EX-101.SCH alim-20211130.xsd EX-101.SCH 2217
5 EX-101.LAB alim-20211130_lab.xml EX-101.LAB 18505
6 EX-101.PRE alim-20211130_pre.xml EX-101.PRE 11438
7 EXTRACTED XBRL INSTANCE DOCUMENT alim-20211130x8k_htm.xml XML 4872
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 211461507
SIC: 2834 Pharmaceutical Preparations